Molecular mechanisms of heptaplatin effective against cisplatin-resistant cancer cell lines: less involvement of metallothionein

BACKGROUND: Heptaplatin is a new platinum derivative with anticancer activity against various cancer cell lines, including cisplatin-resistant cancer cell lines (Cancer Chemother Pharmacol 1995; 35: 441). METHODS: Molecular mechanisms of heptaplatin effective against cisplatin-resistant cancer cell...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Choi, Cheol-Hee, Cha, Yoon-Jung, An, Chun-San, Kim, Kyung-Jong, Kim, Kweon-Cheon, Moon, Sung-Pyo, Lee, Zang Hee, Min, Young-Don
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2004
Matèries:
Primary Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC533863/
https://ncbi.nlm.nih.gov/pubmed/15494073
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2867-4-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars